BHARAT BIOTECH FILES FOR EMERGENCY USE LISTING FOR COVAXIN

Highlights

• Bharat Biotech told Indian government that the remaining documents are most likely to be submitted by June

• The vaccine developed by the Hyderabad-based company has already received regulatory approval from 11 countries

According to the sources, Indian biotechnology company Bharat Biotech International Limited (BBIL) told the government of India that it has already submitted 90% of document....